Marcin Trojanowski, MD
Basic profileMarcin Trojanowski is a Rheumatology/Immunology physician affiliated with Boston University. OpenAlex indexes 32 publications with 530 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AmgenProgram year20254 paymentsResearch$28,465
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20257 payments$9,058
- NovartisProgram year20253 paymentsResearch$8,522
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
36.3%Folate Analog Metabolic Inhibitor11.1%Methotrexate100%Part D≥49 patientsNonsteroidal Anti-inflammatory Drug9.1%Celecoxib100%Part D≥26 patients+ 6 more classes in this area
Nervous system
18.9%Opioid Agonist6.8%Tramadol Hcl71%Oxycodone Hcl29%Part D<11 patientsGabapentinoids6.1%Gabapentin82%Pregabalin18%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
18.4%Corticosteroid8.3%Prednisone100%Part D≥35 patientsProton pump inhibitor8.1%Omeprazole72%Pantoprazole Sodium28%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
David Felson, MD
Boston University
Gary Balady, MD
Boston University
Andrew Budson, MD
Boston University
Jeffrey Samet, MD, MPH
Boston University
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”